Insider Stock Trading History of Groninger James G


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Groninger James G since year 2005. The trader's CIK number is 1013420. At the time of this reporting, Groninger James G is the Director of Nps Pharmaceuticals Inc . (stock ticker symbol NPSP). See this page for all insider trading activities at Nps Pharmaceuticals Inc .

Note that in the past GRONINGER JAMES G also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Groninger James G since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2014-02-13 NPSP Nps Pharmaceuticals Inc Sale 6,000 37.70 226,200
2014-02-13 NPSP Nps Pharmaceuticals Inc Option Ex 15,188 .00 0
2013-12-23 NPSP Nps Pharmaceuticals Inc Option Ex 3,000 21.73 65,190
2013-12-23 NPSP Nps Pharmaceuticals Inc Sale 3,000 29.50 88,500
2013-08-20 NPSP Nps Pharmaceuticals Inc Option Ex 10,000 4.24 42,400
2013-08-20 NPSP Nps Pharmaceuticals Inc Sale 16,900 23.21 392,215
2013-02-07 NPSP Nps Pharmaceuticals Inc Sale 5,325 8.74 46,540
2007-06-18 CYDS Cygne Designs Inc Option Ex 500 .13 65
2006-04-17 CYDS Cygne Designs Inc Option Ex 7,650 .15 1,132
2006-01-10 CYDS Cygne Designs Inc Sale 5,500 4.96 27,280
2006-01-11 CYDS Cygne Designs Inc Sale 1,050 4.95 5,197
2006-01-17 CYDS Cygne Designs Inc Option Ex 1,300 .16 208
2006-01-17 CYDS Cygne Designs Inc Sale 1,300 5.00 6,500
2006-01-10 CYDS Cygne Designs Inc Option Ex 5,500 .91 4,988
2006-01-11 CYDS Cygne Designs Inc Option Ex 1,050 .22 231
2005-07-28 NPSP Nps Pharmaceuticals Inc Sale 1,000 10.87 10,870
2005-05-23 NPSP Nps Pharmaceuticals Inc Sale 2,350 12.74 29,939

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Groninger James G (Director of Nps Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.